TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · major macro event coming up
LMAT

LeMaitre Vascular Inc

Healthcare · Medical Instruments & Supplies

81.50$ +0.9% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

LeMaitre Vascular Inc (LMAT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 641 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet LMAT
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
101 102 107 112 121 126 129 137 144 153 160 163 170 188 185 256 262 253 247 247 289 293 292 299 302 310 315 326 334 347 354 363 377 552 556 578 598 616 630 641
68 59 63 68 76 80 84 92 87 94 95 98 100 92 90 92 102 94 91 90 134 140 141 148 153 162 165 174 182 195 203 213 227 402 408 430 452 468 478 488
35 24 26 30 38 19 23 20 20 26 15 13 12 12 11 20 29 27 24 22 17 14 16 21 17 19 17 19 18 24 27 22 21 26 25 27 25 28 27 27
35 24 26 30 38 42 45 53 46 48 47 48 45 33 31 25 34 27 24 22 67 70 71 76 80 83 81 90 97 105 108 113 124 300 303 319 343 359 367 376
12 13 14 15 14 15 15 15 13 16 15 16 15 17 17 18 20 20 20 21 20 20 21 22 20 22 25 26 24 25 30 31 32 30 35 37 32 34 36 36
17 20 21 20 21 21 22 22 24 26 27 29 32 35 35 40 40 39 39 39 39 41 41 42 42 45 49 49 51 52 54 57 57 56 56 57 71 70 71 71
7.5 8.0 9.3 9.5 11 12 12 12 13 14 14 14 14 15 15 16 14 15 15 32 17 32 31 32 31 18 19 21 – – – – – – – – – – – –
18 23 24 24 24 24 24 24 32 30 30 30 32 40 40 66 66 66 66 66 66 66 66 66 66 66 66 66 66 66 66 66 66 66 66 66 66 66 66 66
5.9 9.9 9.5 9.1 8.7 8.2 7.8 7.4 12 14 13 13 17 25 24 63 61 59 57 56 54 53 51 50 48 47 46 44 43 42 40 39 37 36 34 33 32 33 32 31
15 14 15 14 15 17 16 16 19 23 27 25 28 40 36 103 101 80 70 61 40 39 35 41 41 42 41 43 45 49 45 44 46 215 208 215 219 222 223 220
12 10 11 9.4 12 13 13 13 16 20 19 17 19 21 17 44 44 25 22 21 22 22 18 23 23 25 24 26 29 30 27 25 29 31 25 31 33 36 33 30
– – – – – – – 10 10 15 1.4 1.7 1.7 1.8 1.7 29 25 4.5 4.6 5.0 1.9 1.9 1.9 1.8 1.8 1.9 2.1 2.4 2.7 2.5 2.5 2.6 2.7 2.7 2.6 2.8 2.8 2.9 3.4 3.4
1.1 1.2 2.2 1.6 1.6 1.5 1.4 1.7 1.6 1.7 2.4 1.4 1.7 2.6 1.4 1.2 2.2 2.4 2.6 2.1 3.1 2.3 2.2 2.8 2.8 2.9 3.4 3.5 4.4 3.7 3.1 2.0 1.7 1.8 2.2 4.9 3.5 3.6 4.2 3.2
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – 5.3 5.2 – – – 37 36 36 28 19 – – – – – – – – – – – – – 168 168 168 168 169 169 169
87 88 92 98 106 110 113 121 125 130 133 138 142 148 149 153 161 173 178 186 249 254 258 258 261 268 274 284 289 298 309 320 331 337 348 363 379 394 407 420
14 15 18 21 25 28 31 38 41 46 48 51 54 57 58 60 65 71 74 80 84 88 91 92 95 98 101 106 110 115 122 130 138 145 152 161 174 185 195 206
19 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 21 21 21 22 22 22 22 22 22 22 22 22 22 23 23 23 23 23 23 24 23 23 25

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?